Essentials: Psychedelics for Treating Mental Disorders | Dr. Matthew Johnson
Listen or watch on your favorite platforms
In this Huberman Lab Essentials episode, my guest is Dr. Matthew Johnson, PhD, a senior researcher for the Center of Excellence for Psilocybin Research and Treatment at Sheppard Pratt’s Institute for Advanced Diagnostics and Therapeutics.
We explore the science and therapeutic potential of psychedelic medicine, including psilocybin, MDMA and LSD. We discuss how these substances can profoundly alter perception and self-identity, providing long-lasting relief from depression, addiction and trauma when used in controlled clinical settings. We also discuss microdosing and emerging research on psychedelics’ potential to support recovery from neurological injuries.
People Mentioned
- Paul Stamets: mycologist, entrepreneur
- David Olson: professor of chemistry, biochemistry and molecular medicine, UC Davis
- Bryan Roth: professor of pharmacology, UNC School of Medicine
This transcript is currently under human review and may contain errors. The fully reviewed version will be posted as soon as it is available.
Become a Huberman Lab Premium member to access full episode transcripts & more
Members also get to submit questions for AMA episodes, plus access to exclusive bonus content. A significant portion of proceeds are donated to fund human scientific research.
Become a Memberor sign in to Huberman Lab Premium
Dr. Matthew Johnson: Psychedelic Medicine
Huberman Lab Essentials are short episodes focused on essential science and protocol takeaways from past full-length Huberman Lab episodes.
Join 800,000+ subscribers to get regular emails on neuroscience, health, and science-related tools from Dr. Andrew Huberman.
You'll also get Andrew's exclusive Daily Blueprint. In it, Andrew shares his daily routine. He also shares practical tools and protocols that you can use to stay productive and maximize your health.
By subscribing, I acknowledge that I have read and understand the Privacy Policy
